A Randomized, Double-Blind Study of Pegylated Liposomal Doxorubicin for the Treatment of AIDS-Related Kaposi's Sarcoma-Reference-Cited by-同舟云学术

A Randomized, Double-Blind Study of Pegylated Liposomal Doxorubicin for the Treatment of AIDS-Related Kaposi's Sarcoma

Published:2007-01-01 Issue:1 Volume:12 Page:114-123
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Cooley Timothy¹,Henry David²,Tonda Margaret³,Sun Steven⁴,O'Connell Martin³,Rackoff Wayne⁴

Affiliation:

1. a Lahey Clinic, Burlington, Massachusetts, USA

2. b Pennsylvania Hospital, Philadelphia, Pennsylvania, USA

3. c ALZA Corporation, Mountain View, California,USA

4. d Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, New Jersey, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the current prevalence of Kaposi's sarcoma complicating HIV infection.Describe the impact of highly active antiretroviral therapy (HAART) on Kaposi's sarcoma complicating HIV infection.Prioritize treatment options for Kaposi's sarcoma complicating HIV infection. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Funder

ALZA Corporation

Johnson & Johnson Pharmaceutical Research & Development

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-1-114

Reference26 articles.

1. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. Swiss HIV Cohort Study;Ledergerber;BMJ,1999

2. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study;Jacobson;J Acquir Immune Defic Syndr,1999

3. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma;Tam;Int J Cancer,2002

4. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy;Jones;J Acquir Immune Defic Syndr,2000

5. Combination antiretroviral therapy and incidence of AIDS-related malignancies;Buchbinder;J Acquir Immune Defic Syndr,1999

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review;Journal of Infection and Chemotherapy;2024-10

2. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus;Clinical Microbiology Reviews;2024-09-12

3. Immunotherapy in HIV-associated Kaposi Sarcoma: Challenges and Prospects;Current Cancer Therapy Reviews;2024-06-05

4. Kaposi-Sarkom;Therapie-Handbuch - Onkologie und Hämatologie;2024

5. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies;Expert Review of Anti-infective Therapy;2023-08-15